Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
Background: In hemodialysis (HD) patients, zinc depletion caused by inadequate intake, malabsorption, and removal by HD treatment leads to erythropoiesis-stimulating agent (ESA) hyporesponsiveness. This study investigated the effects of zinc supplementation in HD patients with zinc deficiency on cha...
Main Authors: | Hiroki Kobayashi, Masanori Abe, Kazuyoshi Okada, Ritsukou Tei, Noriaki Maruyama, Fumito Kikuchi, Terumi Higuchi, Masayoshi Soma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-05-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6643/7/5/3783 |
Similar Items
-
Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage
by: Tetsuya Furukawa, et al.
Published: (2015-12-01) -
Blood leptin levels and erythropoietin requirement in Iranian hemodialysis patients
by: Rahimi A, et al.
Published: (2008-12-01) -
Erythropoietin Resistance in Hemodialysis Patients
by: Jacović Saša, et al.
Published: (2019-03-01) -
The assessment of native erythropoietin and antibodies to recombinant erythropoietin in haemodialysis patients
by: Benjamin, Sherilene Cheryl
Published: (2008) -
The assessment of native erythropoietin and antibodies to recombinant erythropoietin in haemodialysis patients
by: Benjamin, Sherilene Cheryl
Published: (2008)